KRTAP5-AS1: A Potential Drug Target and Biomarker (G338651)

Target Name: KRTAP5-AS1

NCBI ID: G338651

KRTAP5-AS1

Other Name(s): KRTAP5-1/KRTAP5-2 antisense RNA 1

KRTAP5-AS1: A Potential Drug Target and Biomarker

KRITC (KRTAP5-AS1) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. KRITC is a key regulator of the cell cycle and has been shown to play a role in a variety of cellular processes, including cell growth, apoptosis, and translation of RNA into protein.

KRITC is expressed in almost all human tissues and has been shown to play a role in the regulation of cell proliferation and differentiation. It has been shown to be involved in the regulation of the G1/S transition, which is the stage of the cell cycle where the cell prepares for cell division. KRITC has also been shown to be involved in the regulation of the G0/G1 transition, which is the stage of the cell cycle where the cell is in a state of growth and division.

In addition to its role in cell cycle regulation, KRITC has also been shown to play a role in the regulation of apoptosis. Apoptosis is a natural process that is involved in the regulation of cell life cycle and is critical for the development and maintenance of multicellular organisms. KRITC has been shown to play a role in the regulation of apoptosis by regulating the expression of genes that are involved in cell death.

Another potential drug target for KRITC is its role in the regulation of translation of RNA into protein. Translation is the process by which RNA molecules are converted into proteins, and it is an essential process for the development and maintenance of multicellular organisms. KRITC has been shown to play a role in the regulation of translation by regulating the expression of genes that are involved in protein synthesis.

KRITC has also been shown to play a role in the regulation of cell signaling pathways. Signal transduction is the process by which cells respond to signals from the environment, and it is an essential process for the development and maintenance of multicellular organisms. KRITC has been shown to play a role in the regulation of signal transduction by regulating the expression of genes that are involved in signaling pathways.

In conclusion, KRITC is a non-coding RNA molecule that has been shown to play a role in a variety of cellular processes, including cell cycle regulation, apoptosis, translation of RNA into protein, and signal transduction. As a result, KRITC is a potential drug target and biomarker for the development of new therapies. Further research is needed to fully understand the role of KRITC in cellular processes and to develop effective treatments.

Protein Name: KRTAP5-1/KRTAP5-2 Antisense RNA 1

The "KRTAP5-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP5-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets